Federation des caisses Desjardins du Quebec’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16 Hold
22
﹤0.01% 2937
2025
Q4
$48 Hold
22
﹤0.01% 2834
2025
Q3
$121 Hold
22
﹤0.01% 2801
2025
Q2
$165 Hold
22
﹤0.01% 2642
2025
Q1
$144 Hold
22
﹤0.01% 2578
2024
Q4
$290 Hold
22
﹤0.01% 2432
2024
Q3
$125 Hold
22
﹤0.01% 2483
2024
Q2
$129 Sell
22
-2
-8% -$18 ﹤0.01% 2365
2024
Q1
$220 Hold
24
﹤0.01% 2294
2023
Q4
$268 Hold
24
﹤0.01% 2244
2023
Q3
$431 Hold
24
﹤0.01% 2225
2023
Q2
$1.34K Buy
24
+1
+4% +$64 ﹤0.01% 2110
2023
Q1
$1.59K Hold
23
﹤0.01% 2105
2022
Q4
$1.41K Hold
23
﹤0.01% 2248
2022
Q3
$2.35K Hold
23
﹤0.01% 2236
2022
Q2
$2.06K Buy
+23
New +$2.81K ﹤0.01% 2301

Other funds holding RBOT

Federation des caisses Desjardins du Quebec's RBOT Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Vicarious Surgical (RBOT) position steady in Q1 2026 at 22 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

Federation des caisses Desjardins du Quebec first reported a position in RBOT in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.35K in Q3 2022. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 22 shares of Vicarious Surgical worth $16 as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Vicarious Surgical share count unchanged in Q1 2026.
  • Vicarious Surgical made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2937 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Vicarious Surgical in Q2 2022 and has held it in 16 quarters since.
  • Federation des caisses Desjardins du Quebec's Vicarious Surgical position peaked at $2.35K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.